← All companies

OGN

Organon & Co.

OGN NYSE Pharmaceutical Preparations EDGAR ↗

$13.56

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$3.56B

Revenue (TTM)

$6.13B

Net income (TTM)

$209M

EPS (TTM)

$0.78

P/E ratio

17.4

Dividend yield

0.59%

Free cash flow

$538M

Cash

$1.13B

Total assets

$13.2B

Gross margin

52.7%

52-week range

$5.69 – $13.60

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 31, 2026 10-Q Quarter ended 2026-06-30 Jul 31, 2026 8-K Shareholder vote results Jul 23, 2026 8-K Other events Jul 17, 2026 8-K Director or officer change; Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Other events Feb 20, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 12, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 10-Q/A Quarter ended 2025-06-30 Nov 10, 2025 10-Q/A Quarter ended 2025-03-31 Nov 10, 2025 10-K/A Fiscal year ended 2024-12-31 Nov 10, 2025 8-K Director or officer change Nov 7, 2025 8-K/A Director or officer change Oct 30, 2025 8-K Director or officer change; Other events Oct 27, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Other events May 27, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 1, 2025 8-K Director or officer change; Regulation FD disclosure Apr 15, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 13, 2025 8-K Director or officer change Jan 21, 2025 8-K Other events Dec 23, 2024 8-K Director or officer change Dec 6, 2024 8-K Regulation FD disclosure Nov 5, 2024 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 31, 2024 8-K Entered a material agreement Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2024 8-K Shareholder vote results Jun 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation May 17, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024